Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • China to regulate all...

    China to regulate all fentanyl drugs as controlled substance

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-04-03T09:00:21+05:30  |  Updated On 3 April 2019 9:00 AM IST
    China to regulate all fentanyl drugs as controlled substance

    China already controls more than two dozen variants of fentanyl, plus two precursors. Data from the U.S. Drug Enforcement Administration has shown that when China bans a variant of fentanyl, seizures of that analogue in the U.S. fall.


    BEIJING: China announced Monday that all fentanyl-related drugs, as a group, would become controlled substances, effective May 1 - a step U.S. officials have long advocated as a way to stem the flow of lethal opioids from China.


    U.S. officials hope that the sweeping change in the way China regulates drugs that mimic fentanyl will help end the game of regulatory whack-a-mole with chemists who can manufacture novel opioids faster than they can be banned. It could help facilitate prosecutions of opioid merchants in China, who until now have skirted the law by manufacturing and exporting fentanyl variants that are technically legal under Chinese law.


    China already controls more than two dozen variants of fentanyl, plus two precursors. Data from the U.S. Drug Enforcement Administration has shown that when China bans a variant of fentanyl, seizures of that analogue in the U.S. fall.


    Monday's announcement from China's Ministry of Public Security, National Health Commission and National Medical Products Administration makes good on a pledge Chinese President Xi Jinping made to President Donald Trump during the G-20 summit in Argentina late last year.


    At the time, Trump said China's new regulations could be "a game changer" for the United States, where tens of thousands of people die annually from opioid overdoses.


    Also Read: China watchdog disciplines 80 officials linked to major vaccine scandal

    BeijingchinaDonald Trumpfentanylfentanyl varietieshealthhealth carelethal opioidsNational Health CommissionNational Medical Products AdministrationopioidseizuresUnited StateUS Drug Enforcement AdministrationXi Jinping
    Source : AP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok